1. The pathophysiology of paroxysmal nocturnal hemoglobinuria.,2007;35:523-33.
2. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria.,1996;87:2546-57.
3. Minor population of CD55-CD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.,2006;107:1308-14.
4. Diagnosis and management of paroxysmal nocturnal hemoglobinuria.,2005;106:3699-709.
5. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.,2007;25:1256-64.